COLO-RECTAL CANCER
Clinical trials for COLO-RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo trial halted early: what it means for patients
Disease control TerminatedThis early-stage trial tested a new drug called MRTX0902, alone or with another drug (adagrasib), in people with advanced solid tumors that have specific KRAS gene mutations. The goal was to check safety and how the body processes the drug. The study was stopped early, so results…
Matched conditions: COLO-RECTAL CANCER
Phase: PHASE1 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Scientists probe immune response to Heat-Based tumor destruction
Knowledge-focused TerminatedThis study looked at how the immune system changes after using radiofrequency ablation (RFA), a treatment that uses heat to destroy lung tumors that spread from colorectal cancer. Researchers planned to study 20 adults with these lung metastases to measure immune cell activity be…
Matched conditions: COLO-RECTAL CANCER
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated Jun 17, 2026 00:28 UTC